See more news releases in: Biotechnology, Health Care & Hospitals, Medical Pharmaceuticals, Pharmaceuticals, Trade Show News

Cadence Pharmaceuticals to Present at Three Investment Conferences During the Month of August 2010

SAN DIEGO, July 27 /PRNewswire-FirstCall/ -- Cadence Pharmaceuticals, Inc. (Nasdaq: CADX), a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting, announced today that the company will present a corporate overview at the following investment conferences:

Wedbush Securities Life Sciences Best Ideas Management Access Conference
Date:	Tuesday, August 3, 2010
Time:	1:35pm Eastern Time (10:35am Pacific Time)
Place:	Le Parker Meridien Hotel in New York City
Speaker:	Ted Schroeder, President & CEO

Canaccord Genuity 30th Annual Growth Conference 2010
Date:	Thursday, August 12, 2010
Time:	1:00pm Eastern Time (10:00am Pacific Time)
Place:	Intercontinental Boston Hotel in Boston
Speaker:	Ted Schroeder, President & CEO

Bank of America Merrill Lynch Specialty Pharmaceuticals Conference
Date:	Friday, August 13, 2010
Time:	8:40am Eastern Time (5:40am Pacific Time)
Place:	Southampton Inn in Southampton, New York
Speaker:	William R. LaRue, SVP & CFO

Each presentation will be simultaneously webcast and can be accessed on Cadence Pharmaceuticals' website at www.cadencepharm.com. To access the presentations, click on the Investor Relations tab the link entitled "Events and Presentations" on the left side of the screen. A replay of each webcast will available approximately three hours after the live webcast concludes and will remain available for 30 days.

About Cadence Pharmaceuticals, Inc.

Cadence Pharmaceuticals is a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting. For more information about Cadence, visit www.cadencepharm.com.

Contacts:

William R. LaRue

SVP, CFO

Cadence Pharmaceuticals, Inc.

858-436-1400

SOURCE Cadence Pharmaceuticals, Inc.

RELATED LINKS
http://www.cadencepharm.com